At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 169 enrolled
Drug / intervention
Lidoderm (Lidocaine 5% Patch) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of the Lidocaine 5% Patch When Used as Adjunct Treatment in Patients With Osteoarthritis of the Knee Receiving Sub-Optimal Pain Relief From Their Current Analgesic Regimen
In Brief
A Phase 2 clinical trial evaluating Lidoderm (Lidocaine 5% Patch) and Placebo Patch for Osteoarthritis of the Knee. Completed, enrolled 169 participants across 20 sites.
Detailed Summary
Patients with knee pain due to Osteoarthritis (OA) experiencing sub-optimal pain relief from their current analgesic regimen will participate in a pilot clinical trial to evaluate the effectiveness and tolerability of the Lidoderm Patch compared with placebo in treating knee pain from OA.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis of the Knee
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2007
First PostedJan 2008
Primary CompletionJun 2008
Study CompletionOct 2008
TodayJul 2026
First PostedJan 10, 2008
Enrollment StartMar 1, 2007
Primary CompletionJun 1, 2008
Study CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 18.5 years ago
Interventions
Lidoderm (Lidocaine 5% Patch)drug
Topical Patch
Placebo Patchdrug
Topical Patch